APA (7th ed.) Citation

Belge Bilgin, G., Burkett, B. J., Bilgin, C., Durski, J. M., Packard, A. T., Navin, P. J., . . . Kendi, A. T. (2026). Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. Journal of Nuclear Medicine, 67(1), 96. https://doi.org/10.2967/jnumed.125.270481

Chicago Style (17th ed.) Citation

Belge Bilgin, Gokce, et al. "Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma." Journal of Nuclear Medicine 67, no. 1 (2026): 96. https://doi.org/10.2967/jnumed.125.270481.

MLA (9th ed.) Citation

Belge Bilgin, Gokce, et al. "Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma." Journal of Nuclear Medicine, vol. 67, no. 1, 2026, p. 96, https://doi.org/10.2967/jnumed.125.270481.